Voltage-gated potassium channel (VGKC) and glutamic acid decarboxylase (GAD) antibodies are increasingly tested in patients with suspected autoimmune encephalitis (AE) and other neurological diseases, yet their clinical significance, especially when detected outside of classic contexts, remains poorly defined. The gene discussed is GAD1; the disease is autoimmune encephalitis.